The conclusion was not surprising to Dr. Steven Quay, the CEO and chairman of the Biotech Company Atossa Therapeutics. In June 2021, he testified ...
News
- House Oversight Committee holds roundtable to review pandemic policy decisions - KABB
- The Lancet Publishes Pivotal Phase 3 Data on CSL's First-in-Class Garadacimab for HAE
... March 1, 2023 /PRNewswire/ -- Global biotechnology leader CSL (ASX:CSL ... Asthma & Immunology (AAAAI) Annual Meeting in San Antonio, Texas.
- Regenxbio: Q4 Earnings Snapshot - MySA
The biotechnology company posted revenue of $31.3 million in the period, which missed ... Japan-based Round1 bowling venue opening in San Antonio ...
- Alector: Q4 Earnings Snapshot - San Antonio Express-News
San Antonio's first car elevator is ready to start accepting cars ... The biotechnology company posted revenue of $14.4 million in the period, ...
- NGM Biopharmaceuticals: Q4 Earnings Snapshot - MySA
Report: San Antonio Rep. ... The biotechnology company posted revenue of $18.2 million in the period, which also topped Street forecasts.